A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case reports in ophthalmological medicine 2017-01, Vol.2017 (2017), p.1-3
Hauptverfasser:	Yıldız, Burçin Kepez, Demir, Gokhan, Perente, Irfan, Erdogan, Gurkan, Eris, Erdem, Aygit, Ebru Demet
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report Case reports Central nervous system depressants Complications and side effects Dexamethasone Diabetes Diabetic retinopathy Macular degeneration Medical imaging Pathogenesis Patients Steroids Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has not been reported in the literature before.
ISSN:	2090-6722 2090-6730
DOI:	10.1155/2017/6369085